[S-42] Symposium 42　Development of new therapeutics in immune-mediated neuropathies: Progress of basic research and clinical trials

[S-42-3] Clinical trials and new treatment strategy in anti-MAG neuropathy

Masanori Nakajima^1,3, Ken-ichi Kaida² (1.Internal Medicine, Morioka Health Cooperative Association, Kawakubo Hospital, Japan, 2.Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan, 3.Department of Neurology, Kyorin University School of Medicine, Japan)

March 2010: Graduated from Saitama Medical University Faculty of Medicine
April 2010: Initial training started in Health Cooperative Saitama, Saitama Cooperative Hospital
March 2012: Initial training completed in Health Cooperative Saitama, Saitama Cooperative Hospital
April 2012: General Internal Medicine in Health Cooperative Saitama, Saitama Cooperative Hospital
April 2013: Internal Medicine in Morioka Health Cooperative Association, Kawakubo Hospital
April 2014: Resident in Department of Neurology, Kyorin University Hospital
April 2015: Medical staff in Department of Neurology, Kyorin University Hospital
April 2020: Assistant Professor (fixed term) in Department of Neurology, Kyorin University School of Medicine
March 2023: Finished Kyorin University Graduate School of Medicine (Department of Internal Medicine and Neurology)
April 2023: Internal Medicine in Morioka Health Cooperative Association, Kawakubo Hospital

Password required to view